News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BG Medicine To Conduct Joint Biomarker Discovery Study For Muscle Toxicity With Mitsubishi Pharma Corporation



3/28/2006 12:36:30 PM

WALTHAM, Mass.--(BUSINESS WIRE)--March 28, 2006--BG Medicine Inc. today announced a collaborative preclinical research study into the biochemical origins of muscle toxicity and associated biomarkers with Mitsubishi Pharma Corporation (Osaka, Japan).

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES